Stay updated on Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:45:33.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added the Lancet Oncology publication citation for SERENA-2 and removed the associated Erratum reference.
    Difference
    0.0%
    Check dated 2026-04-05T06:18:14.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Naples, Italy, 80131 was added as a study location and Napoli, Italy, 80131 was replaced with the English name Naples. The page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T16:55:24.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Publication entry for SERENA-2 (Lancet Oncol. 2024) and its erratum added; the entry revision updated from v3.4.2 to v3.4.3 to reflect this change.
    Difference
    0.1%
    Check dated 2026-03-07T13:00:44.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    - Page revision updated from v3.4.1 to v3.4.2. No substantive changes to core study details were observed.
    Difference
    0.0%
    Check dated 2026-02-14T04:37:16.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.4.0 to v3.4.1, with no visible changes to study information.
    Difference
    0.0%
    Check dated 2026-02-07T05:06:27.000Z thumbnail image

Stay in the know with updates to Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.